CAS NO: | 888958-26-7 |
包装 | 价格(元) |
10 mM * 1 mL in DMSO | 电议 |
5mg | 电议 |
10mg | 电议 |
50mg | 电议 |
100mg | 电议 |
200mg | 电议 |
生物活性 | SARS-CoV-IN-2 is an effective inhibitor ofSARS-CoVreplication. SARS-CoV-IN-2 shows anti-Coronavirus activity with anEC50of 1.9 μM in Vero cells. SARS-CoV-IN-2 inhibits the 3D7 and W2 strains ofP. falciparumwithIC50s of 21.5 and 30 nM; andIC90s of 51.0 and 99.9 nM; respectively. SARS-CoV-IN-2 reducesHIV-1-induced cytopathic effect with anEC50of 2.9 μM in MT-4 cells. Antimalarial and Antiviral Activities[1]. | ||||||||||||||||
IC50& Target |
| ||||||||||||||||
体外研究 (In Vitro) | SARS-CoV-IN-2 (Compound 3) inhibits in vitro growth ofPlasmodium falciparumfar better than Chloroquine (CQ)[1]. | ||||||||||||||||
分子量 | 455.72 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C24H18ClFeN3O | ||||||||||||||||
CAS 号 | 888958-26-7 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
| ||||||||||||||||
溶解性数据 | In Vitro: DMSO : 19.23 mg/mL(42.20 mM;Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
*以上所有助溶剂都可在本网站选购。 |